PATHWAY-RCT: Preventing Admission To Hospital With Attr cardiomyopathY

Abroad (travel likely)Recruiting

Conditions

Cardiac Amyloidosis

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Richmond Research Institute, London, London, United Kingdom
Contact: Study coordinator (Dominic Pimenta, MBBS MRCP BSc (Hons) · grants@richmondresearchinstitute.org
Contact: Principal Investigator (Jorg Taubel, MD FFPM)

Study leads

Tamer Rezk, MBBS MRCP PhD
Principal Investigator
National Amyloidosis Centre, Royal Free Hospital

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Multicenter Study for the Validation of an AI-based ECG Platform for Early Cardiac Amyloidosis Diagnosis

Transthyretin Cardiac Amyloidosis

Abroad (travel likely)Recruiting

Evanston, United States · Toulouse, France

Elevated Rate Pacing of Cardiac Amyloidosis

Cardiac Amyloidosis · Pacemaker

Abroad (travel likely)Recruiting

Minneapolis, United States

Cardiac Amyloidosis pRevaleNce of in OLDer Subjects Affected by Heart Failure

Cardiac Amyloidosis

Abroad (travel likely)Recruiting

Paris, France · Nantes, France

NatiOnal Referral cenTEr Study of Transthyretin Amyloid Cardiomyopathy(ATTR) Patients on Tafamidis

Amyloidosis · Amyloidosis Cardiac · ATTR Amyloidosis Wild Type

Abroad (travel likely)Recruiting

Pavia, Italy